Special Gazette, 21 August 2019

21 August 2019
- application/pdf PDF (301.95 KB) | application/vnd.openxmlformats-officedocument.wordprocessingml.document DOCX (163.42 KB)


  • Final Regulatory Decision for the reconsideration of methiocarb—4
  • Reasons for the affirmation of approvals—6
  • Annexure 1: Affirmed representative label components—9

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.